Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Sprinklr Announces Second Quarter Fiscal 2025 Results
-
LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
Pinstripes Reports Fiscal 2025 First Quarter Results And Updated Fiscal 2025 Guidance
-
NeuroPace Strengthens Management Team with Two Key Appointments
-
Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
-
Serve Robotics to Present at H.C. Wainwright's Annual Global Investment Conference
-
Marketing Executive Lisa Campbell Appointed to the Dynatrace Board of Directors
-
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
-
Lam Research Corporation Announces Participation at Upcoming Conference
-
Amundi US Declares Monthly Distributions for the Pioneer Closed-End Funds
-
SS&C to Host 2024 Analyst Day
-
Curbline Properties Publicly Files Form 10 with SEC
-
NYSE to Commence Delisting Proceedings with Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)
-
Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024
-
Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma
-
Couchbase Announces Second Quarter Fiscal 2025 Financial Results
-
Spero Therapeutics to Present at Upcoming September Investor Conferences
-
ACM Research Receives Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center
-
MediaAlpha and Insurify Extend Publishing Partnership with New Multi-Year Agreement
-
Mondelēz International Selects 10 Start-Ups to Participate in Second CoLab Tech Accelerator Program
-
Nasdaq Reports August 2024 Volumes
-
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
-
Bitfarms to Present at H.C. Wainwright 26th Annual Global Investment Conference
-
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
-
XPO Provides North American LTL Operating Data for August 2024
-
Credo Technology Group Holding Ltd Reports First Quarter of Fiscal Year 2025 Financial Results
-
U.S. Global Investors Announces Fiscal Year 2024 Results Webcast
-
Concrete Pumping Holdings Reports Third Quarter Fiscal Year 2024 Results
-
HubSpot to Host Analyst Day at INBOUND on September 18, 2024
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
iLearningEngines Announces Participation in the H.C. Wainwright Global Investment Conference
-
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalwor
-
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
-
Bolt Biotherapeutics Announces Changes to its Board of Directors
-
Pineapple Energy Welcomes Andy Childs as Interim Chief Financial Officer
-
QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer’s disease
-
ACM Research Receives Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center
-
Paylocity Announces Definitive Agreement to Acquire Airbase Inc., a Leading Spend Management Software Solution Provider
-
V2X, INC. ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK
-
Phreesia Announces Second Quarter Fiscal 2025 Results
-
BRIXMOR PROPERTY GROUP ANNOUNCES THIRD QUARTER 2024 EARNINGS RELEASE AND TELECONFERENCE DATES
-
OnMed Welcomes Healthcare Executives Heyward Donigan and Ken Goulet to its Board of Directors
-
Micromem Confirms Meeting Date with Chevron
-
Align Technology to Speak at Upcoming Financial Conference
-
Satellogic Welcomes Kelly Kennedy to Board of Directors
-
Liberty Global to Present at the Goldman Sachs European Communacopia Conference
-
Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
-
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
